{"id":"W2170032136","doi":"10.1136/thoraxjnl-2011-200393","title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation","year":2011,"lang":"en","type":"article","venue":"Thorax","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":496,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; University of Colorado Denver; National Institutes of Health; National Center for Research Resources; Georgia Clinical and Translational Science Alliance; Vertex Pharmaceuticals; University of Washington; Nationwide Children's Hospital; University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Harvard Catalyst; Case Western Reserve University; Washington University in St. Louis; Harvard University; Hospital for Sick Children; Northwestern University; Cystic Fibrosis Foundation Therapeutics; Children's Hospital of Philadelphia","keywords":"Cystic fibrosis; Medicine; Placebo; Cystic fibrosis transmembrane conductance regulator; Tolerability; Pharmacodynamics; Adverse effect; Pharmacokinetics; Sweat test; Internal medicine; Discontinuation; Gastroenterology; Sweat gland; Pharmacology; Pathology; SWEAT","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003538261,0.001537153,0.002676964,0.0003678754,0.0005659708,0.000750408,0.0008119216,0.001983569,0.003712201],"category_scores_gemma":[0.001917512,0.000779219,0.001600817,0.0003148942,0.001281542,0.0007116785,0.0002777578,0.002180636,0.001043686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005133939,"about_ca_system_score_gemma":0.001124837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009153224,"about_ca_topic_score_gemma":0.001327166,"domain_scores_codex":[0.9988205,0.0006999123,0.00008019457,0.000155679,0.00009007923,0.0001535415],"domain_scores_gemma":[0.9981346,0.000589183,0.0003099905,0.0001818994,0.0002006338,0.0005837313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8565949,0.04660174,0.005875379,0.0007151212,0.001745036,0.0003595068,0.0002672143,0.0007463706,0.05483078,0.00008392099,0.001423609,0.03075647],"study_design_scores_gemma":[0.4708631,0.5077343,0.01601088,0.00002774618,0.001020867,0.0001841105,0.00004053882,0.0002641265,0.002711341,0.00005456083,0.001064246,0.0000241299],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894161,0.00279208,0.00108156,0.0004069242,0.0001594662,0.003114963,0.001383364,0.00009846106,0.001547125],"genre_scores_gemma":[0.9887277,0.00190752,0.001690609,0.0007417437,0.0002119272,0.002272811,0.00227897,0.00003361314,0.002135141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003712201,"threshold_uncertainty_score":0.01871234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06009892135269617,"score_gpt":0.3495034684645923,"score_spread":0.2894045471118961,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}